The U.S. Food and Drug Administration has proposed a program that would allow earlier access to high-risk medical devices to treat or diagnose patients with serious conditions whose needs are currently unmet.
Supply Chain
One year after the launch of Irving, Texas-based aptitude's online contracting market, the first of its kind in the healthcare industry, the company is reporting a combined purchasing power of more than $10 billion.
From 2012 to 2013, the average salary for healthcare supply chain professionals rose by approximately 5 percent, from $83,391 to $88,342, according to Healthcare Purchasing News' 2013 salary survey.
UPS has released its sixth annual "Pain in the (Supply) Chain" survey, gathering attitudes, concerns and outlooks from healthcare supply chain executives on the future of materials management.
European pharmaceutical giants Novartis and GlaxoSmithKline have announced a three-part transaction worth more than $20 billion, according to a GSK news release.
The U.S. Food and Drug Administration has approved Cyramza (ramucriumab) as a treatment for patients with advanced stomach cancer and a form of cancer located where the esophagus meets the stomach.
Two hospitals — Sacred Heart in Pensacola, Fla., and St. Mary's of Michigan in Saginaw — are responsible for saving millions of dollars at their own facilities as well as a nationwide network of hospitals due to an innovative approach…
Andover, Mass.-based Philips Healthcare has temporarily stopped manufacturing CT scanners and molecular imaging equipment at its facility in Cleveland, according to a DOTmed report.
Lake Forest, Ill.-based Hospira has voluntarily recalled seven lots of its Propofol Injectable Emulsion, USP, citing metal particulate embedded in the interior neck of the vial as well as free-floating metal particulates found in the vials.
More than eight out of 10 high-risk devices approved through premarket approval for pediatric use were not studied in patients less than 18 years old, according to a study in Pediatrics.